- Revenue for the fourth quarter of 2024 is anticipated to be in the range of $239.5 million to $239.7 million, an approximately 25% increase over the same quarter of 2023
- Revenue for full year 2024 is anticipated to be in the range of $802.6 million to $802.8 million, an approximately 28% increase over full year 2023
- Activated 72 new centers in the U.S. in the fourth quarter of 2024, bringing the total to 1,435 U.S. medical centers implanting Inspire therapy
- Created 12 new sales territories in the U.S. in the fourth quarter of 2024, bringing the total to 335 U.S. sales territories
- Initiated the soft launch of the Inspire V neurostimulator with over 40 implants completed in Singapore and the U.S.
- Implemented a new organizational structure intended to drive continued growth
Initial Full Year 2025 Revenue Guidance
- Revenue for full year 2025 is anticipated to be in the range of $940 million to $955 million, a 17% to 19% increase over full year 2024
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.